159 unknown. 159 Phase 1, 77 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 159 | Unknown 159 |
| Phase 2 | 77 | Unknown 77 |
Follow Colonic Diseases: new trials by email Literature Review of Colonic Diseases trials Research Report on Colonic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Single and Multiple Ascending Doses of H021 in Healthy Participants H021, H021 Placebo - Ulcerative Colitis | Phase 1 | Unknown | Jiangsu Carephar Pharmaceutical Co., Ltd. | 64 | 2024-09-17 | 2024-10-04 |
| Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer Irinotecan Liposome, Bevacizumab - Metastatic Colorectal Cancer | Phase 1 / Phase 2 | Unknown | West China Hospital | 20 | 2024-08-09 | 2024-08-09 |
| Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer Liposomal irinotecan, Bevacizumab - Colorectal Cancer | Phase 1 / Phase 2 | Unknown | Sun Yat-sen University | 74 | 2024-06-05 | 2024-05-30 |
| A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer T3011 hepatic artery infusion, toripalimab, regorafenib - Colorectal Cancer Metastatic | Phase 1 | Unknown | China Medical University, China | 8 | 2024-04-02 | 2024-02-29 |
| Fecal Transplantation in Patients Colonic Diverticulitis Fecal Microbiome, Placebo - Diverticulitis, Colonic, Colon Inflamed | Phase 1 | Unknown | Odense University Hospital | 40 | 2024-04-01 | 2024-04-05 |
| Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) WM-A1-3389, Pembrolizumab - Advanced Solid Tumor, Metastatic Solid Tumor | Phase 1 | Unknown | Wellmarker Bio | 54 | 2024-03-14 | 2024-03-12 |
| Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer Irinotecan Liposome, Oxaliplatin, 5-FU - Metastatic Colorectal Cancer | Phase 1 | Unknown | Shanghai Zhongshan Hospital | 78 | 2024-03-11 | 2024-03-19 |
| Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors UCMYM802 Injection - Malignant Mesothelioma, Colorectal Cancer | Phase 1 | Unknown | UTC Therapeutics Inc. | 24 | 2024-03-05 | 2024-07-24 |
| Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease Adalimumab-680LT, Control - Crohn Disease, Ulcerative Colitis | Phase 1 / Phase 2 | Unknown | University Medical Center Groningen | 21 | 2024-03-01 | 2024-03-12 |
| A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. TQB2618 injection, Penpulimab injection, Anlotinib hydrochloride capsules - Colorectal Cancer | Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 75 | 2024-01-13 | 2024-01-23 |
| A Study of HY-0102 in Patients With Advanced Solid Tumors HY-0102 - Advanced Solid Tumor | Phase 1 | Unknown | Shanghai YingLi Pharmaceutical Co. Ltd. | 50 | 2023-12-18 | 2024-06-13 |
| Pilot Study of a New Medical Food in the Management of Ulcerative Colitis Soluble protein hydrolysate (SPHi) - Ulcerative Colitis | Phase 1 | Unknown | Stanford University | 25 | 2023-12-01 | 2023-11-03 |
| Tumor Antigen-sensitized DC Vaccine for Colorectal Cancer Liver Metastases Tumor antigen-sensitized DC vaccine - Carcinoma, Colorectal Cancer | Phase 1 | Unknown | West China Hospital | 10 | 2023-11-01 | 2024-08-09 |
| Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent PB101 - Solid Tumor, Adult, Solid Tumor | Phase 1 | Unknown | Panolos Bioscience | 30 | 2023-10-25 | 2024-02-23 |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors CEA CAR-T cells - Gastric Cancer, Colon Cancer | Phase 1 | Unknown | Chongqing Precision Biotech Co., Ltd | 36 | 2023-09-30 | 2023-11-08 |
| A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors SON-DP - Solid Tumor, Breast Cancer | Phase 1 | Unknown | Qurgen Inc. | 150 | 2023-09-19 | 2024-04-24 |
| CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors CEA-targeted CAR-T cells - Gastric Cancer, Colon Cancer | Phase 1 / Phase 2 | Unknown | Chongqing Precision Biotech Co., Ltd | 60 | 2023-09-07 | 2024-08-09 |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis Paclitaxel - Peritoneal Carcinomatosis | Phase 1 | Unknown | National University Hospital, Singapore | 36 | 2023-08-04 | 2024-05-29 |
| A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors RC198 Injection - Melanoma, Urothelial Carcinoma | Phase 1 | Unknown | RemeGen Co., Ltd. | 48 | 2023-06-05 | 2024-08-16 |
| IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors IMM2520 - Advanced Solid Tumor, Non-small Cell Lung Cancer | Phase 1 | Unknown | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | 48 | 2023-03-23 | 2023-06-07 |
Showing 20 of 159. Sign in to see all of them.
Colorectal Neoplasms (113) · Colonic Neoplasms (37) · Pancreatic Neoplasms (35) · Stomach Neoplasms (24) · Breast Neoplasms (23) · Colitis, Ulcerative (18) · Carcinoma, Hepatocellular (16) · Carcinoma, Non-Small-Cell Lung (16) · Lung Neoplasms (16) · Neoplasm Metastasis (14) · Rectal Neoplasms (14) · Ovarian Neoplasms (13) · Esophageal Neoplasms (11) · Head and Neck Neoplasms (10) · Melanoma (10)
Digestive System Diseases (159) · Gastrointestinal Diseases (159) · Intestinal Diseases (159) · Digestive System Neoplasms (138) · Intestinal Neoplasms (138) · Neoplasms by Site (138) · Gastrointestinal Neoplasms (130) · Neoplasms (130) · Rectal Diseases (115) · Neoplasms by Histologic Type (41) · Endocrine Gland Neoplasms (37) · Endocrine System Diseases (37) · Neoplasms, Glandular and Epithelial (36) · Pancreatic Diseases (35)
Oxaliplatin (10) · Capecitabine (9) · Fluorouracil (8) · Irinotecan (8) · Leucovorin (7) · pembrolizumab (7) · Bevacizumab (6) · regorafenib (6) · Cetuximab (5) · irinotecan sucrosofate (4) · toripalimab (4) · Folfox protocol (3) · Gemcitabine (3) · HMPL-013 (3) · Immunotherapy, Adoptive (3)
Sun Yat-sen University (4) · China Medical University, China (3) · Chinese Academy of Medical Sciences (3) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (3) · Radboud University Medical Center (3) · Aronex Pharmaceuticals (2) · Betta Pharmaceuticals Co., Ltd. (2) · Chongqing Precision Biotech Co., Ltd (2) · First Affiliated Hospital of Chengdu Medical College (2) · Fudan University (2) · Haihe Biopharma Co., Ltd. (2) · Jonsson Comprehensive Cancer Center (2) · NGM Biopharmaceuticals, Inc (2) · National Taiwan University Hospital (2) · Poniard Pharmaceuticals (2)
China (60) · United States (31) · South Korea (10) · United Kingdom (6) · Netherlands (5) · Australia (4) · Denmark (4) · Taiwan (4) · Canada (3) · Germany (3) · Switzerland (3) · Israel (2) · Singapore (2) · Spain (2) · Sweden (2)
Jin Li, MD (2) · Lee S. Rosen, MD (2) · Lin Yang, Ph.D. (2) · Robert Earhart, MD, PhD (2) · Aiwu R. He, MD (1) · Albert Yu, MD (1) · Ann-Li Cheng, M.D. (1) · Antonio Avallone, M.D. (1) · Anup Kasi, MD (1) · Beverley A de Valois, PhD (1) · Bing Liu, M.D. (1) · Bok Yan Jimmy So, MBChB (1) · Braden Kuo, MD (1)
PMID 16564913, PMID 20371346, PMID 20959411, PMID 22461641, PMID 22589701, PMID 23648372, PMID 24351336, PMID 24497570, PMID 24641416, PMID 24668644, PMID 25213161, PMID 25421252, PMID 25467588, PMID 25621950, PMID 25631767, PMID 25747273, PMID 25805929, PMID 25981818, PMID 25983002, PMID 26228759, PMID 26755520, PMID 26808342, PMID 26871284, PMID 27032509, PMID 27347147, PMID 27558635, PMID 27756258, PMID 27916294, PMID 28054442, PMID 28161329, PMID 28412099, PMID 28415728, PMID 29506548, PMID 29881409, PMID 30522017, PMID 30642373, PMID 31164456, PMID 31272391, PMID 31409768, PMID 31432232, PMID 31739095, PMID 31819192, PMID 32711004, PMID 33184339, PMID 33188747, PMID 33462499, PMID 33571293, PMID 33829355, PMID 34155211, PMID 35276694
2016 (1), 2017 (1), 2019 (1), 2023 (1), P30CA015083 (1)